Clinical features and laboratory findings for differentiating parkinsonian syndromes

Journal of Neurology, Supplement

Volumn 249, Issue 3, 2002, Pages

  Benecke, Reiner ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Autonomic dysfunction; Imaging; Parkinson's disease; Parkinsonian syndromes; Transcranial magnetic stimulation

Indexed keywords

2BETA CARBOXY 3BETA(4 IODOPHENYL)TROPANE I 123; ALPHA SYNUCLEIN; ATAXIN 2; FLUORODOPA F 18; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; LEVODOPA; PARKIN; PROTEIN; RADIOPHARMACEUTICAL AGENT; UBIQUITIN; UNCLASSIFIED DRUG;

AUTONOMIC NERVOUS SYSTEM; BRAIN INFARCTION; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG INDUCED DISEASE; ECHOENCEPHALOGRAPHY; ENCEPHALITIS; GENE LOCUS; HISTOPATHOLOGY; HUMAN; IMAGING SYSTEM; LABORATORY TEST; METABOLIC DISORDER; NEUROENDOCRINE SYSTEM; NEUROPHYSIOLOGY; PARKINSONISM; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; REVIEW;

DIAGNOSIS, DIFFERENTIAL; HUMANS; LEVODOPA; PARKINSONIAN DISORDERS;

EID: 0036392452     PISSN: 09391517     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Bandmann O, Daniel S, Marsden CD, Wood NW, Harding AE (1996) The GTP-cyclohydrolyse I gene in atypical parkinsonian patients: a clinico-genetic study. J Neurol Sci 141:27-32
2. Becker G, Seufert J, Bogdahn U, Reichmann H, Reiners K (1995) Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography. Neurology 45:182-184
3. Berg D, Siefker C, Becker G (2001) Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings. J Neurol 248:684-689
4. Braune S (2001) The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes. Clin Autonomic Res 11:351-355
5. Brooks DJ (1997) Neuroimaging of movement disorders. In: Watts RL, Koller WC (eds) Movement disorders: neurologic principles and practice. New York, NY: McGraw-Hill Book Co, pp 31-48
6. Brown RG, Marsden CD (1984) How common is dementia in Parkinson's disease? Lancet 2:1262-1265
7. Clarke CE, Ray PS, Speller JM (1999) Failure of the clonidine growth hormone stimulation test to differentiate multiple system atrophy from early or advanced idiopathic Parkinson's disease. Lancet 353:1329-1330
8. Collins SJ, Ahlskog JE, Parisi JE, Maraganore DM (1995) Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. J Neurol Neurosurg Psychiatry 58:167-173
9. Colosimo C, Albanese A, Hughes AJ, de Bruin VMS, Lees AJ (1995) Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson disease. Arch Neurol 52:294-298
10. Cummings JL (1998) Intellectual impairment in Parkinson's disease: clinical, pathologic, and biochemical correlates. J Geriatr Psychiatry Neurol 1:24-36
11. Daniel SE, De Bruin VM, Lees AJ (1995) The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal. (Review) Brain 118:759-770
12. Druschky A, Hilz MJ, Platsch G, et al. (2000) Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT. J Neurol Sci 175:3-12
13. Farrer M, Gwinn-Hardy K, Muenter M, et al. (1999) A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor. Hum Mol Genet 8:81-85
14. Funayama M, Hasegawa K, Kowa H, Saito M, Tsuji S, Obata J (2002) A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1. Ann Neurol 51:296-301
15. Gasser T, Muller-Myhsok B, Wszolek ZK, Oehlmann R, Calne DB, Bonifati V, Bereznai B, Fabrizio E, Vieregge P, Horstmann RD (1998) A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat Genet 18:262-265
16. Gibb WRG, Luthert PJ, Marsden DC (1989) Corticobasal degeneration. Brain 112:1171-1192
17. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427-442
18. Hohl U, Tiraboschi P, Hansen LA, Thal LJ, Corey-Bloom J (2000) Diagnostic accuracy of dementia with Lewy bodies. Arch Neurol 57:347-351
19. Hughes AJ, Colosimo C, Kleedorfer B, Daniel SE, Lees AJ (1992) The dopaminergic response in multiple system atrophy. J Neurol Neurosurg Psychiatry 55:1009-1013
20. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181-184
21. Hughes AJ, Daniel SE, Lees AJ (1993) The clinical features of Parkinson's disease in 100 histologically proven cases. Adv Neurol 60:595-599
22. Hughes AJ, Daniel SE, Lees AJ (2001) Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology 57:1497-1499
23. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ (2002) The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 125:861-870
24. Kaufmann J, Oribe E, Miller M, Knott P, Wiltshire-Clement M, Yahr MD (1992) Hypotension induced vasopressin release distinguishes between pure autonomic failure and multiple system atrophy with autonomic failure. Neurology 42:590-593
25. Kim YJ, Ichise M, Ballinger JR, Vines D, Erami SS, Tatschida T, Lang AE (2002) Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP. Mov Disord 2:303-312
26. Kimber JR, Watson L, Mathias CJ (1997) Distinction of idiopathic Parkinson's disease from multiple-system atrophy by stimulation of growth-hormone release with clonidine. Lancet 349:1877-1881
27. Kitada T, Asakawa S, Hattori N, et al. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392:605-608
28. Klein C, Brown R, Wenning G, Quinn N (1997) The "Cold hands sign" in multiple system atrophy. Mov Disord 4:514-518
29. Kofler M, Mueller J, Reggiani L, Wenning GK (2000) Somatosensory evoked potentials in progressive supranuclear palsy. J Neurol Sci 179:85-91
30. Lees AJ, Smith E (1983) Cognitive deficits in the early stages of Parkinson's disease. Brain 106:257-270
31. Leroy E, Boyer R, Auburger G, et al. (1998) The ubiquitin pathway in Parkinson's disease. Nature 395:451-452
32. Litvan I, Agid Y, Jankovic J, Goetz C, Brandel JP, Lai EC, et al. (1996) Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson Olszewski syndrome). Neurology 46:922-930
33. Litvan I, Goetz CG, Jankovic J, Wenning GK, Booth V, Bartko JJ, et al. (1997) What is the accuracy of the clinical diagnosis of multiple system atrophy? Arch Neurol 54:937-944
34. Litvan I, MacIntyre A, Goetz CG, Wenning GK, Jellinger K, Verny M, et al. (1998) Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Arch Neurol 55:969-978
35. Louis ED, Fahn S (1996) Pathologically diagnosed diffuse Lewy body disease and Parkinson's disease: do the parkinsonian features differ? Adv Neurol 69:311-314
36. Louis ED, Klarka LA, Liu Y, Fahn S (1997) Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's disease. Neurology 48:376-380
37. Mark MH, Sage JI, Dickson DW, Schwarz KO, Duvoisin RC (1992) Levodopa-nonresponsive Lewy body parkinsonism. Clinicopathologic study of two cases. Neurology 42:1323-1327
38. Martin WE, Loewenson RB, Resch JA, Baker AB (1973) Parkinson's disease: clinical analysis of 100 patients. Neurology 23:783-790
39. McKeith IG, Perry EK, Perry RH, for the Consortium on Dementia with Lewy bodies (1999). Report of the second dementia with Lewy body international workshop: diagnosis and treatment. (Review) Neurology 53:902-905
40. McNaught KS, Jenner P (2001) Proteasomal function is impaired in substantia nigra in Parkinson's disease. Neurosci Lett 297:191-194
41. Olanow CW (1992) Magnetic resonance imaging in parkinsonism. Neurol Clin 10:405-420
42. Owen AM, Janes M, Leigh PN, Summers BA, Marsden CD, Quinn NP, Lange KW, Robbins TW (1992) Frontostriatal cognitive deficits at different stages of Parkinson's disease. Brain 115:1727-1751
43. Polymeropoulos MH, Lavedan C, Leroy E, Die SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276:2045-2047
44. Rajput AH, Rosdilsky B, Rajput A (1991) Accuracy of clinical diagnosis in parkinsonism: a prospective study. Can J Neurol Sci 18:275-278
45. Rajput AH (1992) Prevalence of dementia in Parkinson's disease. In: Huber SJ, Cummings JL (eds) Parkinson's disease: neurobehavioral Aspects. New York, NY: Oxford University Press, pp 119-131
46. Riley DE, Lang AE (2000) Clinical diagnostic criteria. (Review) Adv Neurol 82:29-34
47. Sakuta M, Nakanishi T, Toyokure Y (1978) Anal muscle electromyograms differ in amyotrophic lateral sclerosis and Shy-Drager syndrome. Neurology 28:1289-1293
48. Schwarz J, Kornhuber M, Bischoff C, Straube A (1997) Electromyography of the external anal sphincter in patients with Parkinson's disease an multiple system atrophy. Frequency of abnormal spontaneous activity and polyphasic motor unit potentials. Muscle Nerve 20:1167-1172
49. Selby G (1984) The Graeme Robertson memorial lecture, 1983: the long-term prognosis of Parkinson's disease. Clin Exp Neurol 20:1-25
50. Shan D-E, Soong B-W, Sun C-M, Lee S-J, Liao K-K, Liu R-S (2001) Spinocerebellar ataxia type 2 presenting as familial deco dopa responsive parkinsonism. Ann Neurol 50:812-815
51. Tandberg E, Larsen JP, Aarsland D, Cummings JL (1996) The occurence of depression in Parkinson's disease: a community-based study. Arch Neurol 53:175-179
52. Tison F, Arne P, Sourgen C, Chrysostome V, Yeklef F (2000) The value of external anal sphincter electromyography for the diagnosis of multiple system atrophy. Mov Disord 6:1148-1157
53. Tranchant C, Guiraud-Chaumeil C, Echaniz-Laguna A, Warter JM (2000) Is clonidine growth hormone stimulation a good test to differentiate multiple system atrophy from idiopathic Parkinson's disease? J Neurol 415:853-856
54. Valente EM, Bentivoglio AR, Dixon PH, et al. (2001) Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36. Am J Hum Genet 68:895-900
55. Valldeoriola F, Valls-Sole J, Tolosa ES, Marti MS (1995) Striatal sphincter denervation in patients with progressive supranuclear palsy. Mov Disord 10:550-555
56. Van Duijn CM, Dekker MC, Bonifati V, et al. (2001) PARK7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36. Am J Hum Genet 69:3
57. Verny M, Jellinger KA, Hauw JJ, Bancher C, Litvan I, Agid Y (1996) Progressive supranuclear palsy: a clinico-pathological study of 21 cases. Acta Neuropathol (Berl) 91:427-431
58. Walter U, Wittstock M, Benecke R, Dressler D (2002) Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease. J Neurol Transm 109:191-196
59. Walter U, Niehaus L, Probst T, Benecke R, Meyer BU, Dressler D (2002) Brain parenchyma sonography discriminates Parkinson's disease from atypical parkinsonian syndromes. Neurology (in press)
60. Wenning GK, Ben-Shlomo Y, Magalhaes M, Daniel SE, Quinn NP (1995) Clinicopathological study of 35 cases of multiple system atrophy. J Neurol Neurosurg Psychiatry 58:160-166
61. Wenning GK, Scherler C, Granata R, Boesch S, Verny M, Chaudhuri KR, Jellinger K, Poewe W, Litvan I (1999) Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study. J Neurol Neurosurg Psychiatry 67:620-623
62. Wolters A, Classen J, Kunesch E, Grossmann A, Benecke R (2002) Function of the corpus callosum as assessed by measurements of the ipsilateral cortical inhibition is abnormal in corticobasal degeneration and progressive supranuclear palsy but normal in idiopathic Parkinson's disease. J Neurol (submitted)
63. Yoshita M (1998) Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine 123 metaiodobenzyl-guanidine myocardial scintigraphy. J Neurol Sci 155:60-67